T regulatory cells, the evolution of targeted immunotherapy

被引：34
|
作者：
Nizar, S. [1 ,2 ]
Meyer, B. [1 ]
Galustian, C. [1 ]
Kumar, D. [2 ]
Dalgleish, A. [1 ]
机构：
[1] St Georges Univ London, Dept Cellular & Mol Med, London SW17 0RE, England
[2] St Georges Hosp NHS Trust, Dept Colorectal Surg, London, England
来源：
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2010年 / 1806卷 / 01期
关键词：
T regulatory; Tregs; FOXP3; Cancer; Immunotherapy; PHASE-II TRIAL; DENILEUKIN DIFTITOX; DENDRITIC CELLS; ANTITUMOR IMMUNITY; CTLA-4; BLOCKADE; TGF-BETA; PERIPHERAL-BLOOD; PROSTATE-CANCER; FUSION PROTEIN; IN-VITRO;
D O I：
10.1016/j.bbcan.2010.02.001
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
T regulatory cells are able to suppress anti-tumour immunity in pre-clinical models and in patients. This review highlights the important discoveries in Treg immunology critical to the evolution of targeted immunotherapy. We also describe the therapeutic applications that are currently being assessed and their future potential. (C) 2010 Elsevier BM. All rights reserved.
引用
收藏
页码：7 / 17
页数：11
相关论文
共 50 条
  • [21] Advance of T regulatory cells in tumor microenvironment remodeling and immunotherapy in pancreatic cancer
    Gao, Zetian
    Zhang, Qiubo
    Zhang, Xie
    Song, Yufei
    EUROPEAN JOURNAL OF INFLAMMATION, 2022, 20
  • [22] The role of regulatory T cells in immunopathogenesis and immunotherapy of viral infections
    Karkhah, Ahmad
    Javanian, Mostafa
    Ebrahimpour, Soheil
    INFECTION GENETICS AND EVOLUTION, 2018, 59 : 32 - 37
  • [23] Functional regulatory T cells and allergen immunotherapy
    Rolland, Jennifer M.
    Gardner, Leanne M.
    O'Hehir, Robyn E.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 10 (06) : 559 - 566
  • [24] Targeting regulatory T cells for immunotherapy in melanoma
    Lili Huang
    Yeye Guo
    Shujing Liu
    Huaishan Wang
    Jinjin Zhu
    Lingling Ou
    Xiaowei Xu
    Molecular Biomedicine, 2
  • [25] Suppression, subversion and escape: the role of regulatory T cells in cancer progression
    Oleinika, K.
    Nibbs, R. J.
    Graham, G. J.
    Fraser, A. R.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 171 (01): : 36 - 45
  • [26] Regulatory T cells, as a target in anticancer immunotherapy
    Enokida, Tomohiro
    Nishikawa, Hiroyoshi
    IMMUNOTHERAPY, 2017, 9 (08) : 623 - 627
  • [27] Manipulation of regulatory T cells and antigen-specific cytotoxic T lymphocyte-based tumour immunotherapy
    Karimi, Shirin
    Chattopadhyay, Subhasis
    Chakraborty, Nitya G.
    IMMUNOLOGY, 2015, 144 (02) : 186 - 196
  • [28] Evaluation of regulatory T-cells in cancer immunotherapy: therapeutic relevance of immune checkpoint inhibition
    Singh, Ranjeet
    Srivastava, Prateek
    Manna, Partha Pratim
    MEDICAL ONCOLOGY, 2024, 41 (02)
  • [29] γδ T cells in cancer immunotherapy
    Zou, Chang
    Zhao, Pan
    Xiao, Zhangang
    Han, Xianghua
    Fu, Fan
    Fu, Li
    ONCOTARGET, 2017, 8 (05) : 8900 - 8909
  • [30] Expanding and converting regulatory T cells: a horizon for immunotherapy
    Khattar, Mithun
    Chen, Wenhao
    Stepkowski, Stanislaw M.
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2009, 57 (03) : 199 - 204
12345